SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

RBC Raises Ligand Pharmaceuticals Price Target to $357

RBC raised its price target on Ligand Pharmaceuticals to $357 from $345 and kept its Outperform rating.

LGND

Related stories